NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
11 hedge funds and large institutions have $867K invested in NeuroMetrix, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
22% more funds holding
Funds holding: 9 → 11 (+2)
43% less capital invested
Capital invested by funds: $1.52M → $867K (-$652K)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$31.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$20.8K |
| 3 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$19.9K |
| 4 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$331 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$505K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$82K |
| 3 |
VF
Virtu Financial
New York
|
-$23.8K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$22.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.59K |
NURO Hedge Fund Activity: Q2 2018 in Review
11 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2018, worth a combined $867K — down 43% from $1.52M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NURO positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $31.1K. The largest seller was Sabby Management, cutting an estimated $505K.
- 11 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2018, up from 9 in Q1 2018.
- Funds reported $867K of NeuroMetrix, Inc. Common Stock stock for Q2 2018, down 43% quarter-over-quarter.
- 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2018 and 1 closed out, a net change of +2 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2018 was Renaissance Technologies, an estimated $31.1K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q2 2018 was Sabby Management, an estimated $505K sold.
Based on aggregated 13F filings for Q2 2018.